Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Guidelines for evaluating myocardial cell death.

Mishra PK, Adameová A, Hill JA, Baines CP, Kang PM, Downey J, Narula J, Takahashi M, Abbate A, Piristine HC, Kar S, Su S, Higa JK, Kawasaki NK, Matsui T.

Am J Physiol Heart Circ Physiol. 2019 Aug 16. doi: 10.1152/ajpheart.00259.2019. [Epub ahead of print]

PMID:
31418596
2.

Highly conductive, stretchable and biocompatible Ag-Au core-sheath nanowire composite for wearable and implantable bioelectronics.

Choi S, Han SI, Jung D, Hwang HJ, Lim C, Bae S, Park OK, Tschabrunn CM, Lee M, Bae SY, Yu JW, Ryu JH, Lee SW, Park K, Kang PM, Lee WB, Nezafat R, Hyeon T, Kim DH.

Nat Nanotechnol. 2018 Nov;13(11):1048-1056. doi: 10.1038/s41565-018-0226-8. Epub 2018 Aug 13.

PMID:
30104619
3.

Correlation between 5-α reductase type 2 protein expression and methylation of 5-α reductase type 2 promotor gene of benign prostatic hyperplasia.

Kang PM, Kim YJ, Seo WT, Kang SH, Kim TS, Chun BK, Seo WI, Jeong JY, Chung JI.

World J Urol. 2019 Apr;37(4):709-718. doi: 10.1007/s00345-018-2422-4. Epub 2018 Aug 1.

PMID:
30069579
4.

A back-to-back tumor composed of papillary renal cell carcinoma and oncocytoma treated by laparoscopic partial nephrectomy: a case report.

Kang SH, Seo WT, Kang PM, Rhew HY, Jeon YH, Cheon BK, Kim TS.

J Med Case Rep. 2018 May 21;12(1):146. doi: 10.1186/s13256-018-1662-7.

5.

Laparoscopic -2port Varicocelectomy with Scarless Periumblical Mini-Incision: Initial Experience in Approach and Outcomes.

Seo WI, Kwon JK, Kang PM, Kim W, Yoon JH, Kim TS, Chung JS, Oh CK.

Urol J. 2018 Mar 18;15(2):10-15. doi: 10.22037/uj.v0i0.3869.

6.

Targeting Oxidative Stress Using Nanoparticles as a Theranostic Strategy for Cardiovascular Diseases.

Kim KS, Song CG, Kang PM.

Antioxid Redox Signal. 2019 Feb 10;30(5):733-746. doi: 10.1089/ars.2017.7428. Epub 2018 Jan 30.

PMID:
29228781
7.

Aldosterone-Sensing Neurons in the NTS Exhibit State-Dependent Pacemaker Activity and Drive Sodium Appetite via Synergy with Angiotensin II Signaling.

Resch JM, Fenselau H, Madara JC, Wu C, Campbell JN, Lyubetskaya A, Dawes BA, Tsai LT, Li MM, Livneh Y, Ke Q, Kang PM, Fejes-Tóth G, Náray-Fejes-Tóth A, Geerling JC, Lowell BB.

Neuron. 2017 Sep 27;96(1):190-206.e7. doi: 10.1016/j.neuron.2017.09.014.

8.

Identification of Novel Non-secosteroidal Vitamin D Receptor Agonists with Potent Cardioprotective Effects and devoid of Hypercalcemia.

Khedkar SA, Samad MA, Choudhury S, Lee JY, Zhang D, Thadhani RI, Karumanchi SA, Rigby AC, Kang PM.

Sci Rep. 2017 Aug 16;7(1):8427. doi: 10.1038/s41598-017-08670-y.

9.

Early Actions of Anti-Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Drugs on Angiogenic Blood Vessels.

Sitohy B, Chang S, Sciuto TE, Masse E, Shen M, Kang PM, Jaminet SC, Benjamin LE, Bhatt RS, Dvorak AM, Nagy JA, Dvorak HF.

Am J Pathol. 2017 Oct;187(10):2337-2347. doi: 10.1016/j.ajpath.2017.06.010. Epub 2017 Jul 21.

10.

Longitudinal changes in erectile function after thulium:YAG prostatectomy for the treatment of benign prostatic obstruction: a 1-year follow-up study.

Chung JS, Park SH, Oh CK, Kim SC, Kim TS, Kang PM, Seo WI, Kim WS, Yoon JH, Kang DI, Min KS, Chung JI.

Lasers Med Sci. 2017 Sep;32(7):1517-1523. doi: 10.1007/s10103-017-2273-z. Epub 2017 Jul 6.

PMID:
28685201
11.

Correlation between postoperative prostate-specific antigen and biochemical recurrence in positive surgical margin patients: Single surgeon series.

Seo WI, Kang PM, Yoon JH, Kim W, Chung JI.

Prostate Int. 2017 Jun;5(2):53-58. doi: 10.1016/j.prnil.2017.02.002. Epub 2017 Mar 3.

12.

Fibrin-Targeted and H2O2-Responsive Nanoparticles as a Theranostics for Thrombosed Vessels.

Kang C, Gwon S, Song C, Kang PM, Park SC, Jeon J, Hwang DW, Lee D.

ACS Nano. 2017 Jun 27;11(6):6194-6203. doi: 10.1021/acsnano.7b02308. Epub 2017 May 18.

PMID:
28481519
13.

Wnt signaling promotes androgen-independent prostate cancer cell proliferation through up-regulation of the hippo pathway effector YAP.

Seo WI, Park S, Gwak J, Ju BG, Chung JI, Kang PM, Oh S.

Biochem Biophys Res Commun. 2017 May 13;486(4):1034-1039. doi: 10.1016/j.bbrc.2017.03.158. Epub 2017 Mar 30.

PMID:
28366633
14.

Neuropeptide Y3-36 incorporated into PVAX nanoparticle improves functional blood flow in a murine model of hind limb ischemia.

Eshun D, Saraf R, Bae S, Jeganathan J, Mahmood F, Dilmen S, Ke Q, Lee D, Kang PM, Matyal R.

J Appl Physiol (1985). 2017 Jun 1;122(6):1388-1397. doi: 10.1152/japplphysiol.00467.2016. Epub 2017 Mar 16.

15.

Hydrogen Peroxide-Responsive Nanoparticle Reduces Myocardial Ischemia/Reperfusion Injury.

Bae S, Park M, Kang C, Dilmen S, Kang TH, Kang DG, Ke Q, Lee SU, Lee D, Kang PM.

J Am Heart Assoc. 2016 Nov 14;5(11). pii: e003697.

16.

Carboxy-terminal deletion of the HDL receptor reduces receptor levels in liver and steroidogenic tissues, induces hypercholesterolemia, and causes fatal heart disease.

Pal R, Ke Q, Pihan GA, Yesilaltay A, Penman ML, Wang L, Chitraju C, Kang PM, Krieger M, Kocher O.

Am J Physiol Heart Circ Physiol. 2016 Dec 1;311(6):H1392-H1408. doi: 10.1152/ajpheart.00463.2016. Epub 2016 Sep 30.

17.

H2O2-responsive antioxidant polymeric nanoparticles as therapeutic agents for peripheral arterial disease.

Kwon B, Kang C, Kim J, Yoo D, Cho BR, Kang PM, Lee D.

Int J Pharm. 2016 Sep 25;511(2):1022-32. doi: 10.1016/j.ijpharm.2016.08.014. Epub 2016 Aug 10.

PMID:
27521705
18.

Computed Tomography Imaging Features and Changes in Hemostatic Agents After Laparoscopic Partial Nephrectomy.

Kim TS, Park JG, Kang H, Kang SH, Rhew HY, Kang PM.

J Endourol. 2016 Sep;30(9):950-7. doi: 10.1089/end.2016.0263. Epub 2016 Jul 15.

PMID:
27310824
19.

Soluble fms-like tyrosine kinase 1 promotes angiotensin II sensitivity in preeclampsia.

Burke SD, Zsengellér ZK, Khankin EV, Lo AS, Rajakumar A, DuPont JJ, McCurley A, Moss ME, Zhang D, Clark CD, Wang A, Seely EW, Kang PM, Stillman IE, Jaffe IZ, Karumanchi SA.

J Clin Invest. 2016 Jul 1;126(7):2561-74. doi: 10.1172/JCI83918. Epub 2016 Jun 6.

20.

Soluble analog of ApoER2 targeting beta2-glycoprotein I in immune complexes counteracts hypertension in lupus-prone mice with spontaneous antiphospholipid syndrome.

Kolyada A, Ke Q, Karageorgos I, Mahlawat P, Barrios DA, Kang PM, Beglova N.

J Thromb Haemost. 2016 Jun;14(6):1298-307. doi: 10.1111/jth.13314. Epub 2016 May 3.

21.

A role of stochastic phenotype switching in generating mosaic endothelial cell heterogeneity.

Yuan L, Chan GC, Beeler D, Janes L, Spokes KC, Dharaneeswaran H, Mojiri A, Adams WJ, Sciuto T, Garcia-Cardeña G, Molema G, Kang PM, Jahroudi N, Marsden PA, Dvorak A, Regan ER, Aird WC.

Nat Commun. 2016 Jan 8;7:10160. doi: 10.1038/ncomms10160.

22.

Hydrogen peroxide-activatable antioxidant prodrug as a targeted therapeutic agent for ischemia-reperfusion injury.

Lee D, Park S, Bae S, Jeong D, Park M, Kang C, Yoo W, Samad MA, Ke Q, Khang G, Kang PM.

Sci Rep. 2015 Nov 13;5:16592. doi: 10.1038/srep16592.

23.

Diagnostic and Therapeutic Nanoparticles in Cardiovascular Diseases.

Tyler PD, Kang PM.

Curr Pharm Des. 2015;21(42):6070-80. Review.

PMID:
26503151
24.

Transutricular seminal vesiculoscopy in the management of symptomatic midline cyst of the prostate.

Kang PM, Seo WI, Yoon JH, Kim TS, Chung JI.

World J Urol. 2016 Jul;34(7):985-92. doi: 10.1007/s00345-015-1689-y. Epub 2015 Sep 20.

PMID:
26387919
25.

Reactive oxygen species-activated nanomaterials as theranostic agents.

Kim KS, Lee D, Song CG, Kang PM.

Nanomedicine (Lond). 2015;10(17):2709-23. doi: 10.2217/nnm.15.108. Epub 2015 Sep 2. Review.

26.

Exaggerated hypertensive response to combretastatin A-4 phosphate in hypertensive rats: Effective pharmacological inhibition by diltiazem.

Ke Q, Samad MA, Bae S, Chaplin DJ, Kang PM.

Vascul Pharmacol. 2015 Nov;74:73-79. doi: 10.1016/j.vph.2015.05.004. Epub 2015 May 16.

PMID:
25989107
27.

p-Hydroxybenzyl alcohol-containing biodegradable nanoparticle improves functional blood flow through angiogenesis in a mouse model of hindlimb ischemia.

Cho BR, Ryu DR, Lee KS, Lee DK, Bae S, Kang DG, Ke Q, Singh SS, Ha KS, Kwon YG, Lee D, Kang PM, Kim YM.

Biomaterials. 2015;53:679-87. doi: 10.1016/j.biomaterials.2015.02.107. Epub 2015 Mar 24.

PMID:
25890763
28.

Endothelin A receptor antagonist, atrasentan, attenuates renal and cardiac dysfunction in Dahl salt-hypertensive rats in a blood pressure independent manner.

Samad MA, Kim UK, Kang JJ, Ke Q, Kang PM.

PLoS One. 2015 Mar 16;10(3):e0121664. doi: 10.1371/journal.pone.0121664. eCollection 2015.

29.

Primary androgen deprivation therapy for prostate cancer in koreans: a retrospective multicenter study.

Seo WI, Kang PM, Kim TH, Moon KH, Chung JM, Lee DH, Kim IY, Min K, Chung J, Kim W, Kang DI.

World J Mens Health. 2014 Dec;32(3):159-66. doi: 10.5534/wjmh.2014.32.3.159. Epub 2014 Dec 29.

30.

A new Mdr2(-/-) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancer.

Ikenaga N, Liu SB, Sverdlov DY, Yoshida S, Nasser I, Ke Q, Kang PM, Popov Y.

Am J Pathol. 2015 Feb;185(2):325-34. doi: 10.1016/j.ajpath.2014.10.013. Epub 2014 Dec 2.

PMID:
25478810
31.

Incidental abnormal FDG uptake in the prostate on 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography scans.

Kang PM, Seo WI, Lee SS, Bae SK, Kwak HS, Min K, Kim W, Kang DI.

Asian Pac J Cancer Prev. 2014;15(20):8699-703.

32.

RhoA signaling in cardiomyocytes protects against stress-induced heart failure but facilitates cardiac fibrosis.

Lauriol J, Keith K, Jaffré F, Couvillon A, Saci A, Goonasekera SA, McCarthy JR, Kessinger CW, Wang J, Ke Q, Kang PM, Molkentin JD, Carpenter C, Kontaridis MI.

Sci Signal. 2014 Oct 21;7(348):ra100. doi: 10.1126/scisignal.2005262.

33.

Abnormal calcium handling and exaggerated cardiac dysfunction in mice with defective vitamin d signaling.

Choudhury S, Bae S, Ke Q, Lee JY, Singh SS, St-Arnaud R, Monte FD, Kang PM.

PLoS One. 2014 Sep 30;9(9):e108382. doi: 10.1371/journal.pone.0108382. eCollection 2014.

34.
35.

Thulium laser (RevoLix) vaporesection versus vapoenucleation with morcellator (Piranha) for the treatment of benign prostatic obstruction: a propensity-matched multicenter analysis.

Chung JS, Kang PM, Seo WI, Oh CK, Kim SC, Park SH, Choi JH, Yoon JH, Kang DI, Chung JI.

Int J Urol. 2014 Nov;21(11):1156-61. doi: 10.1111/iju.12547. Epub 2014 Jul 14.

36.

FOXO1-mediated activation of Akt plays a critical role in vascular homeostasis.

Dharaneeswaran H, Abid MR, Yuan L, Dupuis D, Beeler D, Spokes KC, Janes L, Sciuto T, Kang PM, Jaminet SS, Dvorak A, Grant MA, Regan ER, Aird WC.

Circ Res. 2014 Jul 7;115(2):238-251. doi: 10.1161/CIRCRESAHA.115.303227. Epub 2014 May 29. Erratum in: Circ Res. 2014 Aug 1;115(4):e9.

37.

Predictive value of the cancer of the prostate risk assessment score for recurrence-free survival after radical prostatectomy in Korea: a single-surgeon series.

Seo WI, Kang PM, Chung JI.

Korean J Urol. 2014 May;55(5):321-6. doi: 10.4111/kju.2014.55.5.321. Epub 2014 May 12.

38.

Therapeutic use of H2O2-responsive anti-oxidant polymer nanoparticles for doxorubicin-induced cardiomyopathy.

Park S, Yoon J, Bae S, Park M, Kang C, Ke Q, Lee D, Kang PM.

Biomaterials. 2014 Jul;35(22):5944-53. doi: 10.1016/j.biomaterials.2014.03.084. Epub 2014 Apr 22.

PMID:
24767791
39.

Korean prostate cancer patients have worse disease characteristics than their American counterparts.

Kang DI, Chung JI, Ha HK, Min K, Yoon J, Kim W, Seo WI, Kang Pm, Jung SJ, Kim IY.

Asian Pac J Cancer Prev. 2013;14(11):6913-7.

40.

Hydrogen sulfide attenuates sFlt1-induced hypertension and renal damage by upregulating vascular endothelial growth factor.

Holwerda KM, Burke SD, Faas MM, Zsengeller Z, Stillman IE, Kang PM, van Goor H, McCurley A, Jaffe IZ, Karumanchi SA, Lely AT.

J Am Soc Nephrol. 2014 Apr;25(4):717-25. doi: 10.1681/ASN.2013030291. Epub 2013 Dec 12.

41.

Hydrogen peroxide-responsive copolyoxalate nanoparticles for detection and therapy of ischemia-reperfusion injury.

Lee D, Bae S, Ke Q, Lee J, Song B, Karumanchi SA, Khang G, Choi HS, Kang PM.

J Control Release. 2013 Dec 28;172(3):1102-10. doi: 10.1016/j.jconrel.2013.09.020. Epub 2013 Oct 2.

42.

H2O2-responsive molecularly engineered polymer nanoparticles as ischemia/reperfusion-targeted nanotherapeutic agents.

Lee D, Bae S, Hong D, Lim H, Yoon JH, Hwang O, Park S, Ke Q, Khang G, Kang PM.

Sci Rep. 2013;3:2233. doi: 10.1038/srep02233.

43.

Inflammation-responsive antioxidant nanoparticles based on a polymeric prodrug of vanillin.

Kwon J, Kim J, Park S, Khang G, Kang PM, Lee D.

Biomacromolecules. 2013 May 13;14(5):1618-26. doi: 10.1021/bm400256h. Epub 2013 Apr 29.

PMID:
23590189
44.

Vitamin D signaling pathway plays an important role in the development of heart failure after myocardial infarction.

Bae S, Singh SS, Yu H, Lee JY, Cho BR, Kang PM.

J Appl Physiol (1985). 2013 Apr;114(8):979-87. doi: 10.1152/japplphysiol.01506.2012. Epub 2013 Feb 21.

45.

Doxercalciferol, a pro-hormone of vitamin D, prevents the development of cardiac hypertrophy in rats.

Choi JH, Ke Q, Bae S, Lee JY, Kim YJ, Kim UK, Arbeeny C, Thadhani R, Kang PM.

J Card Fail. 2011 Dec;17(12):1051-8. doi: 10.1016/j.cardfail.2011.08.006. Epub 2011 Sep 9.

46.

Mechanisms and inhibitors of apoptosis in cardiovascular diseases.

Singh SS, Kang PM.

Curr Pharm Des. 2011;17(18):1783-93. Review.

PMID:
21631422
47.

Novel pharmacological therapies for cardiac hypertrophy and heart failure.

Kang PM.

Curr Pharm Des. 2011;17(18):1773. No abstract available.

PMID:
21631418
48.

Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats.

Bae S, Yalamarti B, Ke Q, Choudhury S, Yu H, Karumanchi SA, Kroeger P, Thadhani R, Kang PM.

Cardiovasc Res. 2011 Sep 1;91(4):632-9. doi: 10.1093/cvr/cvr133. Epub 2011 May 11.

49.

Mitochondria to nucleus translocation of AIF in mice lacking Hsp70 during ischemia/reperfusion.

Choudhury S, Bae S, Ke Q, Lee JY, Kim J, Kang PM.

Basic Res Cardiol. 2011 May;106(3):397-407. doi: 10.1007/s00395-011-0164-1. Epub 2011 Mar 9.

50.

Delayed activation of caspase-independent apoptosis during heart failure in transgenic mice overexpressing caspase inhibitor CrmA.

Bae S, Siu PM, Choudhury S, Ke Q, Choi JH, Koh YY, Kang PM.

Am J Physiol Heart Circ Physiol. 2010 Nov;299(5):H1374-81. doi: 10.1152/ajpheart.00168.2010. Epub 2010 Sep 10.

Supplemental Content

Support Center